Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paladin Labs Inc Insider Profile
4 Followers
Paladin Labs Inc, Shareholder at Aurinia Pharmaceuticals, holds 10.62M shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Paladin Labs Inc ― shares of Aurinia Pharmaceuticals on ― for an estimated value of ―.
Paladin Labs Inc has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Paladin Labs Inc's holdings
Insider Roles
Shareholder
Roles that Paladin Labs Inc holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paladin Labs Inc
Paladin Labs Inc's Trading History
List of latest transactions for each holding click on a transaction to see Paladin Labs Inc's performance on stock
You May Also Like
Paladin Labs Inc insider profile FAQ
What is the percentage of profitable transactions made by Paladin Labs Inc?
The percentage of profitable transactions made by Paladin Labs Inc is ―.
What is the average return per transaction made by Paladin Labs Inc?
The average return per transaction made by Paladin Labs Inc is ―.
What stocks does Paladin Labs Inc hold?
Paladin Labs Inc holds: AUPH stocks.
What was Paladin Labs Inc’s latest transaction?
Paladin Labs Inc latest transaction was an Uninformative Buy of ―.
What was Paladin Labs Inc's most profitable transaction?
Paladin Labs Inc’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paladin Labs Inc's role in Aurinia Pharmaceuticals?
Paladin Labs Inc's role in Aurinia Pharmaceuticals is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.